MECLIZINE 25 (MECLIZINE HYDROCHLORIDE) TABLET, CHEWABLE [PD-RX PHARMACEUTICALS, INC.]

MECLIZINE 25 (MECLIZINE HYDROCHLORIDE) TABLET, CHEWABLE [PD-RX PHARMACEUTICALS, INC.]
PDF | XML

NDC 43063-804-01, 43063-804-06, 43063-804-12, 43063-804-20, 43063-804-30
Set ID cf79ac74-017e-4fb4-85d3-4ea944080e89
Category HUMAN OTC DRUG LABEL
Packager PD-Rx Pharmaceuticals, Inc.
Generic Name
Product Class Antiemetic
Product Number
Application Number PART336
  • SPL UNCLASSIFIED SECTION

    Drug Facts

    Close
  • Active Ingredients (in each chewable tablet)

    Meclizine 25 mg

    Close
  • Purpose

    Antiemetic

    Close
  • Indications and Usage

    prevents and treats nausea, vomiting, dizziness associated with motion sickness:

    Close
  • Warnings

    • Do not use for children under 12 years of age unless directed by a doctor.

    Do not take unless directed by a doctor if you have

    • glaucoma
    • trouble urinating due to an enlarged prostate gland
    • a breathing problem such as emphysema or chronic bronchitis

    Do not take if you are taking sedatives or tranquilizers, without first consulting your doctor.

    When using this product

    • do not exceed recommended dosage
    • drowsiness may occur
    • avoid alcoholic drinks
    • alcohol, sedatives, and tranquilizers may increase drowsiness
    • be careful when driving a motor vehicle or operating machinery

    If pregnant or breast-feeding,

    • ask health professional before use.

    Keep out of reach of children.

    In case of overdose, get medical help or contact a Poison Control Center right away. 1-800-222-1222

    Close
  • Directions

    Dosage should be taken 1 hour befor travel starts.

    Adults and children 12 years and over: Take 1 or 2 tablets once daily, or as directed by doctor.
    Close
  • Inactive ingredients

    Croscarmellose sodium, dextrose, FD& C Red #40, flavor, magnesium stearate, microcrystalline cellulose, silicon dioxide, sodium saccharine, stearic acid

    Close
  • Questions?

    Adverse drug event call (866) 562-2756 (M-F, 8AM-4PM EST).

    Close
  • How Supplied

    Meclizine 25mg are supplied as chewable pink round scored tablets with PH 051 embossed on them.

    Supplied in bottles of 6, 12 , 20, 30 and 100 chewable tablets.

    Close
  • PRINCIPAL DISPLAY PANEL - 25 mg Bottle Label


    Antiemetic

    Each chewable tablet contains:

    Meclizine HCl

    25 mg

    Store at 68°-77°F (20°-25°C)

    Tamper evident by foil seal under cap.

    Do not use if foil seal is broken or missing.

    image

    Close
  • INGREDIENTS AND APPEARANCE
    MECLIZINE 25 
    meclizine hydrochloride tablet, chewable
    Product Information
    Product Type HUMAN OTC DRUG Item Code (Source) NDC:43063-804
    Route of Administration ORAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    MECLIZINE HYDROCHLORIDE (UNII: HDP7W44CIO) (MECLIZINE - UNII:3L5TQ84570) MECLIZINE HYDROCHLORIDE 25 mg
    Inactive Ingredients
    Ingredient Name Strength
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
    DEXTROSE (UNII: IY9XDZ35W2)  
    FD&C RED NO. 40 (UNII: WZB9127XOA)  
    SACCHARIN SODIUM (UNII: SB8ZUX40TY)  
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    Product Characteristics
    Color white Score no score
    Shape ROUND Size 9mm
    Flavor Imprint Code PH;051
    Contains     
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:43063-804-12 12 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product 11/27/2017 11/30/2027
    2 NDC:43063-804-20 20 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product 01/12/2018 11/30/2027
    3 NDC:43063-804-01 100 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product 02/08/2018 11/30/2027
    4 NDC:43063-804-30 30 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product 03/15/2018 11/30/2027
    5 NDC:43063-804-06 6 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product 07/23/2018 11/30/2027
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    OTC monograph final part336 11/27/2017 11/30/2027
    Labeler - PD-Rx Pharmaceuticals, Inc. (156893695)
    Registrant - PD-Rx Pharmaceuticals, Inc. (156893695)
    Establishment
    Name Address ID/FEI Business Operations
    PD-Rx Pharmaceuticals, Inc. 156893695 repack(43063-804)
    Close